Literature DB >> 3921172

Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect.

U Goldbourt, E Holtzman, H N Neufeld.   

Abstract

The association of serum total and high density lipoprotein cholesterol values with 15 year mortality was examined in a cohort of 10 059 Israeli male civil servants and municipal employees aged 40 and above. In 618 of 1664 deaths in the cohort (37%) coronary heart disease was documented as the cause of death. Risk of mortality was analysed by quintiles. Neither total mortality nor coronary heart disease mortality rose with serum cholesterol concentrations up to 5.6 mmol/1 (216 mg/100 ml), representing 60% of the sample. Rates rose appreciably only in the highest quintile (cholesterol concentration greater than 6.2 mmol/1; greater than 241 mg/100 ml). High density lipoprotein cholesterol was similarly, although inversely, associated with total mortality when expressed as a percentage of total cholesterol. The inverse association of high density lipoprotein cholesterol with coronary heart disease mortality was, in contrast, continuous. These data support the hypothesis that over most of the range of cholesterol values coronary mortality risk and total mortality risk are nearly independent of total cholesterol and most probably independent of low density lipoprotein cholesterol values. In multivariate analysis a low concentration of high density lipoprotein cholesterol appeared to be more predictive of mortality than a high concentration of total cholesterol. The latter was very weakly related to mortality from all causes after multivariate adjustment. It is concluded that the findings of this and other major epidemiological studies support the notion of a "threshold effect." Success in reducing mortality through the pharmacological reduction of serum cholesterol in hypercholesterolaemic patients does not warrant a similar approach in people with average or slightly above average values. These findings appear to provide support for a "high risk strategy" in reducing the risk of coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921172      PMCID: PMC1415871          DOI: 10.1136/bmj.290.6477.1239

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  19 in total

1.  An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel.

Authors:  J J Groen; J H Medalie; H N Neufeld; E Riss; C A Bachrach; F W Mount; H Smith
Journal:  Isr J Med Sci       Date:  1968 Mar-Apr

2.  The search for an optimum serum cholesterol.

Authors:  W B Kannel; T Gordon
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

3.  The optimum serum cholesterol.

Authors: 
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

4.  Associations of serum high density lipoprotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10 000 men.

Authors:  S Yaari; S Even-Zohar; H N Neufeld
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies.

Authors:  A R Dyer; J Stamler; O Paul; R B Shekelle; J A Schoenberger; D M Berkson; M Lepper; P Collette; S Shekelle; H A Lindberg
Journal:  J Chronic Dis       Date:  1981

6.  Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study.

Authors:  I Holme; A Helgeland; I Hjermann; P Leren; P G Lund-Larsen
Journal:  Am J Epidemiol       Date:  1980-07       Impact factor: 4.897

7.  Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men.

Authors:  I Hjermann; K Velve Byre; I Holme; P Leren
Journal:  Lancet       Date:  1981-12-12       Impact factor: 79.321

8.  Oversimplification of diet: coronary heart disease relationships and exaggerated diet recommendations.

Authors:  R Reiser
Journal:  Am J Clin Nutr       Date:  1978-05       Impact factor: 7.045

9.  Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease.

Authors:  C Ehnholm; J K Huttunen; P Pietinen; U Leino; M Mutanen; E Kostiainen; J Pikkarainen; R Dougherty; J Iacono; P Puska
Journal:  N Engl J Med       Date:  1982-09-30       Impact factor: 91.245

10.  Myocardial ischaemia, risk factors and death from coronary heart-disease.

Authors:  G Rose; P S Hamilton; H Keen; D D Reid; P McCartney; R J Jarrett
Journal:  Lancet       Date:  1977-01-15       Impact factor: 79.321

View more
  19 in total

1.  Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.

Authors:  Mrinalini Kulkarni; Peter D Reaven
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

2.  Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners.

Authors: 
Journal:  Occas Pap R Coll Gen Pract       Date:  1992-03

Review 3.  Lipid lowering drugs.

Authors:  P O'Connor; J Feely; J Shepherd
Journal:  BMJ       Date:  1990-03-10

Review 4.  Strength training and lipoprotein-lipid profiles. A critical analysis and recommendations for further study.

Authors:  P F Kokkinos; B F Hurley
Journal:  Sports Med       Date:  1990-05       Impact factor: 11.136

5.  Apoproteins: predictors of coronary heart disease?

Authors:  M Ball; J I Mann
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

Review 6.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

7.  High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men.

Authors:  S J Pocock; A G Shaper; A N Phillips; M Walker; T P Whitehead
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

8.  Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

Authors:  A Inazu; X C Jiang; T Haraki; K Yagi; N Kamon; J Koizumi; H Mabuchi; R Takeda; K Takata; Y Moriyama
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 9.  The potential role of soluble fibre in the treatment of hypercholesterolaemia.

Authors:  A J Coats
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

10.  Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Authors:  Z Chen; R Peto; R Collins; S MacMahon; J Lu; W Li
Journal:  BMJ       Date:  1991-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.